Unlocking Industry Opportunities Through Social Prescribing
🌍 Unlocking Industry Opportunities Through Social Prescribing
Join the Global Movement for Prevention, Wellbeing, and Inclusive Growth
🧭 What is Social Prescribing?
Social prescribing is a transformative approach to health and wellbeing, connecting individuals to non-clinical support in their communities, such as arts, culture, nature, physical activity, volunteering, and more. It moves care beyond medicine by
addressing the social, emotional, and practical needs that underpin health.
The Global Social Prescribing Alliance (GSPA) brings together governments, health systems, businesses, and civil society to
embed social prescribing in national and global health strategies.
💼 Why Industry Should Care
The future of healthcare is shifting from treatment to prevention, from hospital beds to community assets, and from fragmented services to
collaborative ecosystems. This transformation creates a multi-billion dollar opportunity for
forward-thinking businesses across technology, health, finance, arts, and lifestyle sectors.
🌟 Opportunities for Industry🧠 HealthTech & Digital Innovation
- Global digital health market expected to reach $660 billion by 2025 (Statista).
- Huge potential to embed social prescribing in electronic health records, referral systems, and personalized wellbeing platforms.
🧘♀️ Lifestyle, Wellness & Sport
- Global wellness economy valued at $5.6 trillion in 2023, forecast to reach $8.5 trillion by 2027 (Global Wellness Institute).
- Social prescribing opens new referral pathways from healthcare to gyms, wellbeing apps, mindfulness, nature therapies, and beyond.
🖼️ Arts, Culture & Nature
- Cultural prescribing programmes have been shown to reduce GP visits by 37% and A&E attendance by 27% (UK NHS studies).
- The global creative economy represents over 3% of global GDP and growing—positioned to become a pillar in preventative health.
📈 Finance, Insurance & Investment
- Preventable diseases cost the global economy $47 trillion in lost output between 2010 and 2030 (World Economic Forum).
- Align investment portfolios with ESG and SDG goals while supporting scalable, community-based health interventions.
💬 Workforce & Learning
- Mental ill health is the leading cause of long-term sickness absence globally, costing economies billions annually.
- Social prescribing-based workplace wellbeing programmes improve retention, resilience, and productivity.
💰 Value Creation & Investment Opportunities
Social prescribing presents a compelling case for value-based investment. As governments and healthcare systems worldwide adopt preventative, holistic models of care, the demand for scalable, community-rooted services is accelerating. For investors and businesses, this means:
- New markets in healthtech, wellness, creative therapies, training, and local infrastructure.
- Tangible returns: For every £1 invested in social prescribing, the NHS sees up to £3.42 in return (UK Department of Health).
- Social impact: Achieve measurable outcomes aligned with SDG 3 (Good Health and Wellbeing), ESG frameworks, and inclusive economic growth.
📣 Join Us – Let’s Build the Future of Health, Together
The Global Social Prescribing Alliance is actively seeking industry partners to:
- Co-create scalable solutions for health and wellbeing
- Support innovation pilots in cities and regions worldwide
- Join our global forums, working groups, and summits
- Invest in evidence-based prevention strategies
Whether you're a startup or global brand, there's a place for you in this movement.
📩 Partner With Us
Are you ready to be part of the global shift toward community-powered health?
👉 Get in touch today to explore partnership opportunities, join our events, or discuss collaboration ideas.
📧 Email: gareth@whis.world
Together, we can build a future where everyone can thrive.
Industry Memberships
Our Philosophy
As a membership organisation, the Global Social Prescribing Alliance (GSPA) brings global communities together to transform healthcare through social prescribing and create inclusive economic opportunities that leave no one behind.
Mission
Empower people to take control of their own health and wellbeing through social prescribing.
Vision
To deliver health and wellbeing for all through integrated, community-led solutions.
PROBLEM
Most healthcare systems today remain focused on treating illness rather than preventing it. This reactive “sick-care” approach often neglects the wider social, emotional, and environmental factors that influence health.
The COVID-19 pandemic exposed deep-rooted health inequalities (related to gender, race, disability, and socioeconomic status), and highlighted the fragility of global health systems. Now, more than ever, there is a need for proactive, community-based approaches.
SOLUTION
GSPA is a global platform that connects patients, clinicians, community organisations, educators, policymakers, and the private sector to
implement social prescribing as a model for prevention, self-care, and holistic wellbeing.
By shifting the focus from illness to wellness, the Global Social Prescribing Alliance empowers people at every
stage of life — from childhood to old age — to manage their own physical, mental, and social health.
We are changing the way people think about their health by:
- Enabling personalised care through community connections.
- Providing access to non-clinical support (e.g., arts, culture, nature, volunteering, physical activity).
- Building sustainable ecosystems that reduce pressure on overstretched healthcare services.
We support people and communities to co-design local solutions that improve health and wellbeing while addressing the wider determinants of health.
#GSPA
Membership Packages
Members support the network by investing in its growth and impact,
gaining access to valuable connections and resources.
Bronze
Entrepreneurs – £750 per year
Ideal for health innovators, start-ups, and micro-businesses focused on wellbeing or community health.
- Speaking opportunities at GSPA events
- Feature in GSPA publications and webinars
- Business support to scale social prescribing-related initiatives
Gold Public Sector and Charitable Organisations – £750 per year
(For charities and public bodies with over £1m annual budgets)
Includes all above benefits, plus:
- Online speaking slots
- Participation in national publications and policy roundtables
- Priority access to policy briefings and case study showcases
Silver
Public Bodies – £1,500 per year
(Over £1m budget per year)
Includes all Gold Public Sector benefits, plus:
- Enhanced engagement with GSPA leadership
- Influence in shaping national and international social prescribing frameworks
SMEs – £1,500 per year
(Turnover between €500k and €1m)
- All standard benefits
- Showcase innovation in monthly news and events
- Pop-up exhibition options during ecosystem events
- Smart matchmaking with ecosystem leaders
Gold
Mid-Sized Companies – £2,000 per year
(Turnover between €1m and €2m)
Includes all SME benefits, plus:
- Co-branding on selected GSPA reports or campaigns
- Strategic input opportunities with GSPA community leaders
Large Companies – £5,000 per year
(Turnover €2m+)
All mid-sized benefits, plus:
- Speaking slots at international events
- Featured banner in our newsletter (annually)
- Thought leadership articles supported by GSPA editorial team
Strategic Partner – £30,000 per year
(Limited number per sector)
- Monthly strategic meetings with GSPA team
- Key Account Manager support
- Featured interview and regular visibility across platforms
- Priority for speaking, sponsorship, and event partnerships
- Access to regional leaders and global collaborations
Platinum Partners
National Industry Excellence Partnership (Limited to 8 partners per country)
Contact gareth@whis.world to discuss.
- Monthly meetings
- Co-planning national activities and campaigns
- Dedicated account management
- Thought leadership profiling
- Twice-yearly feature spotlight
- Exclusive access to partnership, investment, and scaling opportunities
Global Industry Excellence Partnership (Limited to 8 partners globally)
Contact gareth@whis.world to discuss.
- Monthly CEO-level meetings
- Global strategic input and visibility
- Leadership features and annual global summit participation
- Opportunities for global expansion of your social prescribing solutions
- Bespoke partnership planning with the GSPA leadership team
Payment can be made by BACS to
Virgin Money Bank , Carlisle - Acct Number: 00011047 - Sort Code: 827024
IBAN: GB52CLYD82702400011047
BIC: CLYDGB21S19
VAT Number 241 8452 14
World Health Innovation Summit CIC 09613254 - Thank you
If VAT is applicable @20%